Biodesix, Inc. BDSX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $25.56M-11.1% | $28.76M+32.1% | $21.77M+8.7% | $20.02M+11.5% | $17.96M-12.1% | ||
| $3.29M+14.5% | $2.87M-4.1% | $2.99M-8.5% | $3.27M+13.9% | $2.87M+18.9% | ||
| $24.26M+5.6% | $22.97M+5.8% | $21.71M-3.1% | $22.41M+9.6% | $20.45M+1.1% | ||
| $31.76M+3.4% | $30.72M+6.6% | $28.82M-3.1% | $29.74M+9.8% | $27.09M+0.1% | ||
| $31.76M+3.4% | $30.72M+6.6% | $28.82M-3.1% | $29.74M+9.8% | $27.09M+0.1% | ||
| -$6.2M-215% | -$1.97M+72.1% | -$7.05M+27.5% | -$9.72M-6.4% | -$9.14M-37.4% | ||
| -24.3%-17.4pp | -6.8%+25.6pp | -32.4%+16.2pp | -48.6%+2.3pp | -50.9%-18.3pp | ||
| $1.98M-4.0% | $2.06M-0.7% | $2.07M+9.3% | $1.9M+12.6% | $1.69M-3.8% | ||
| -$1.59M+20.9% | -$2.01M-20.9% | -$1.67M+4.8% | -$1.75M+11.0% | -$1.97M-22.7% | ||
| -$7.79M-95.8% | -$3.98M+54.3% | -$8.72M+24.0% | -$11.47M-3.3% | -$11.1M-34.5% | ||
| -30.5%-16.7pp | -13.8%+26.2pp | -40%+17.2pp | -57.3%+4.5pp | -61.8%-21.4pp | ||
| -$0.81-88.4% | -$0.43+62.9% | -$1.16-1,350% | -$0.08+94.7% | -$1.52-47.6% | ||
| -$0.81-88.4% | -$0.43+62.9% | -$1.16-1,350% | -$0.08+94.7% | -$1.52-47.6% | ||
| 9.7M+27.9% | 7.6M+0.7% | 7.5M-94.9% | 146.7M+1,909% | 7.3M+12.8% | ||
| 9.7M+27.9% | 7.6M+0.7% | 7.5M-94.9% | 146.7M+1,909% | 7.3M+12.8% | ||
| $4.21M-13.8% | $4.88M+18.8% | $4.11M+1.9% | $4.03M+8.9% | $3.7M-14.7% | ||
| $5K+400% | $1K-85.7% | $7K-73.1% | $26K-64.4% | $73K-29.1% | ||
| $385K— | —— | $409K+702% | $51K-48.0% | $98K— | ||
| -$6.2M-215% | -$1.97M+72.1% | -$7.05M+27.5% | -$9.72M-6.4% | -$9.14M-37.4% | ||
| -$4.81M-728% | -$580K+89.7% | -$5.65M+31.8% | -$8.28M-7.6% | -$7.7M-48.0% | ||
| -$4.81M-728% | -$580K+89.7% | -$5.65M+31.8% | -$8.28M-7.6% | -$7.7M-48.0% | ||
| -18.8%-16.8pp | -2%+23.9pp | -25.9%+15.4pp | -41.4%+1.5pp | -42.9%-17.4pp | ||
| -$6.2M-215% | -$1.97M+72.1% | -$7.05M+27.5% | -$9.72M-6.4% | -$9.14M-37.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Biodesix, Inc.'s revenue?
- Biodesix, Inc. (BDSX) generated $96.1M in revenue over the trailing twelve months, up 29.0% year over year.
- Is Biodesix, Inc. profitable?
- Biodesix, Inc. is not currently profitable: it reported a net loss of $32.0M over the trailing twelve months, a -33.3% net margin.
- What is Biodesix, Inc.'s earnings per share?
- Biodesix, Inc.'s diluted EPS over the trailing twelve months is $-2.48.
- Where does Biodesix, Inc.'s income statement data come from?
- Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
